Skip to main content
. 2019 Feb 23;32(1):e100026. doi: 10.1136/gpsych-2018-100026

Table 1A.

The usage of high D2 receptor antagonistic effect antipsychotics

Antipsychotics EPS group Non-EPS group
Risperidone monotherapy 40 70
Paliperidone monotherapy 8 42
Ziprasidone monotherapy 3 6
High D2 receptor antagonistic effect antipsychotics polytherapy 44 68